IDEAYA Biosciences Inc.

The momentum for this stock is not very good. IDEAYA Biosciences Inc. is not a good value stock. IDEAYA Biosciences Inc. is not a good growth stock. IDEAYA Biosciences Inc. is not very popular among insiders. IDEAYA Biosciences Inc. is a mediocre stock to choose.
Log in to see more information.
IDYA Fundamental Data by TradingView

News

IDEAYA Biosciences (NASDAQ:IDYA) PT Raised to $68.00 at Stifel Nicolaus
IDEAYA Biosciences (NASDAQ:IDYA) PT Raised to $68.00 at Stifel Nicolaus

Zolmax IDEAYA Biosciences (NASDAQ:IDYA - Get Free Report) had its price target lifted by Stifel Nicolaus from $63.00 to $68.00 in a note issued to investors on Tuesday, Benzinga reports. The firm presently...\n more…

IDEAYA Biosciences (NASDAQ:IDYA) PT Raised to $68.00 at Stifel Nicolaus
IDEAYA Biosciences (NASDAQ:IDYA) PT Raised to $68.00 at Stifel Nicolaus

Ticker Report IDEAYA Biosciences (NASDAQ:IDYA - Get Free Report) had its price objective upped by research analysts at Stifel Nicolaus from $63.00 to $68.00 in a report issued on Tuesday, Benzinga reports. The...\n more…

Ideaya Biosciences price target raised by $5 at Stifel, here's why
Ideaya Biosciences price target raised by $5 at Stifel, here's why

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Brokerages Set IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Target Price at $55.70
Brokerages Set IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Target Price at $55.70

Ticker Report IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) has been given a consensus rating of "Buy" by the thirteen research firms that are covering the stock, Marketbeat reports. Twelve research...\n more…

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Position Reduced by Candriam S.C.A.
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Position Reduced by Candriam S.C.A.

Ticker Report Candriam S.C.A. reduced its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 0.2% in the 2nd quarter, according to the company in its most recent 13F filing with the...\n more…

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PR Newswire IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire SOUTH SAN...\n more…